Ebglyss

Ebglyss (lebrikizumab) is a prescription medication used to treat Atopic dermatitis (eczema). An injectable biologic for moderate-to-severe atopic dermatitis (eczema) in adults and adolescents when topical treatments aren't enough.

Blocks interleukin-13 (IL-13), a key protein that drives the inflammation and itch of eczema.

Commonly reported side effects of Ebglyss include Eye and eyelid inflammation, Injection site reactions, Shingles, and Allergic reactions. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Ebglyss does not carry an FDA Boxed Warning, but every prescription medicine has risks and possible interactions. Always follow your doctor's instructions and read the medication guide that comes with it.

The active ingredient in Ebglyss is lebrikizumab, which belongs to a class of medicines known as IL-13 Inhibitor (Biologic).

Ebglyss is manufactured by Eli Lilly. It was first approved in 2024.

You may be able to lower the cost of Ebglyss by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.